In the process of bringing a new drug to market, every day counts— especially during clinical development, when delays can add up to millions of dollars in added expenses and lost revenues. Using Kinship Trial Design, companies are able to:

Minimize the risk of trial design
Better formulate assumptions
Quantify uncertainty
Guide decision making and planning of trials
Lower the cost of clinical trials
Reduce the drug development time-to-market

Development team members of diverse disciplines use the Kinship Trial Design to conduct a series of simulations of variations on a trial. By varying the simulation input parameters, the team can test the impact of changes in the knowledge base, assumptions about the drug and subjects, and variations in the trial design on the range of probable results. Before starting each actual clinical trial, teams are able to answer questions such as:

- What is the optimal treatment schedule of a drug for a particular indication?

- What is the expected range of response?

- How will a change in inclusion/exclusion criteria affect outcome?

- How frequently should the response be measured?

- What is the impact of poor compliance and how can the trial design be improved?